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ABSTRACT
HIV-1 integrase (IN) oligomerization and DNA
recognition are crucial steps for the subsequent
events of the integration reaction. Recent
advances described the involvement of stable
intermediary complexes including dimers and tet-
ramers in the in vitro integration processes, but
the initial attachment events and IN positioning
on viral ends are not clearly understood. In order
to determine the role of the different IN oligomeric
complexes in these early steps, we performed
in vitro functional analysis comparing IN prepara-
tions having different oligomerization properties.
We demonstrate that in vitro IN concerted integra-
tion activity on a long DNA substrate contain-
ing both specific viral and nonspecific DNA
sequences is highly dependent on binding of pre-
formed dimers to viral ends. In addition, we show
that IN monomers bound to nonspecific DNA can
also fold into functionally different oligomeric
complexes displaying nonspecific double-strand
DNA break activity in contrast to the well known
single strand cut catalyzed by associated IN. Our
results imply that the efficient formation of the
active integration complex highly requires the
early correct positioning of monomeric integrase
or the direct binding of preformed dimers on the
viral ends. Taken together the data indicates that
IN oligomerization controls both the enzyme spec-
ificity and activity.
INTRODUCTION
The HIV-1 integration of viral DNA into the cellular
genome catalyzed by integrase (IN) is a key step in the
biological cycle of the virus. In the ﬁrst step, IN removes
two nucleotides from both 30-ends of the blunt-ended
DNA generated by reverse transcriptase (RT). In the
second step, the resulting 30 OH ends, through a trans-
steriﬁcation reaction, integrate the processed viral molec-
ule into the target DNA with a cleavage site separated by
5bp in the case of HIV. In the cells, the viral DNA is part
of a large nucleoprotein complex called the pre-integration
complex (PIC) (1). Integrase and other viral and cellular
factors are associated with the viral DNA in the PIC and
transported to the nucleus where integration takes place.
PIC puriﬁed from infected cells can integrate the viral
DNA in vitro with a high ﬁdelity and display the hall-
marks of HIV-1 integration (2–4).
Both 30 processing and strand transfer can be partially
reproduced in vitro by using DNA substrates mimicking
the viral ends and pure recombinant IN (5–7). However, in
these assays, only one viral end is cleaved and/or inte-
grated (half site integration, HSI) in contrast to the two
viral LTR integration process observed in vivo (full-site
integration, FSI). More recent studies have shown that
in vitro recombinant IN is able to catalyze concerted inte-
gration in the absence of other cofactors (8–10). However,
in addition to the requirement of nonphysiological
compounds such as PEG and DMSO, HSI always
appeared more tolerant to the reaction conditions than
FSI. This suggests that in vitro IN does not fold in a
proper active structure. Some parameters are known
to improve FSI, such as the use of unprocessed
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data obtained concerning the concerted integration reac-
tion, the diﬀerent requirements for FSI and HSI remains
still obscure.
Functional analysis of the IN DNA complexes using
chemical crosslink, time-resolved ﬂuorescence anisotropy
and two-dimensional gel electrophoresis revealed speciﬁc
reaction intermediates (12–14). Data indicate that, retro-
viral DNA integration occurs in the context of a series of
highly stable nucleoprotein complexes called stable synap-
tic complex (SSC) and strand transfer complex (STC),
leading to a tetrameric IN complex bound to both viral
and target DNA (13).
This sequence of events leading to the formation of
the integration complex remains unclear, particularly the
initial association between IN and DNA leading to the
tetramer associated with both viral ends. At least three
questions remain to be answered: (i) How the positioning
of IN takes place on the viral ends? (ii) Does the IN
monomer play a role in this early step of the integration
process? (iii) Does the IN dimerize after binding to the
LTR leading to an association into the tetrameric form?
Previously, multimerization of IN following interaction
with DNA was revealed by small angle X-ray scattering
(SAXS) and time-resolved ﬂuorescence anisotropy
(15–17). Those results strongly suggest the involvement
of diﬀerent IN oligomers depending on the nature of the
DNA substrate.
Here we provide a functional study of the diﬀerent IN
oligomers populations found in solution. Comparison of
IN activity using enzymes at diﬀerent oligomerization
states showed that the integration activity was highly
dependent both on viral end sequences for the formation
of speciﬁc IN oligomers, or the presence of preformed
catalytically active oligomers in solution. Our data also
demonstrate that multimerization of IN on nonspeciﬁc
DNA leads to the formation of a new functional variant
of IN able to generate nonspeciﬁc random double-strand
breaks. Taken together our ﬁndings strongly suggest that
(i) enzyme speciﬁcity is determined by its oligomeriza-
tion and (ii) the initial binding of the enzyme to the viral
extremities, and thus its correct positioning on the LTRs,
constitutes a prerequisite step in the formation of active
complexes.
MATERIALS AND METHODS
HIV-1 IN
Standard puriﬁcation was performed essentially as pre-
viously described (18). The soluble fraction containing
the HIV-1 IN obtained from JSC 310 (IN), expressing
IN protein was loaded on a Hitrap butyl-sepharose 4B
column (1ml, Pharmacia-LKB), washed with LSC buﬀer
(50mM HEPES pH 7.6, 0.2M NaCl, 0.1mM EDTA,
1mM DTT, 7mM CHAPS, 10% glycerol) and equili-
brated with 5 volumes HSC buﬀer (50mM HEPES pH
7.6, 0.2M NaCl, 1M ammonium sulfate, 0.1mM EDTA,
1mM DTT, 7mM CHAPS). Proteins were eluted by a
decreasing ammonium sulfate gradient (1–0M).
Fractions containing IN activity were pooled and 7mM
CHAPS was added. Pooled fractions were 1/3 diluted
with 50mM HEPES pH 7.6, 0.1mM EDTA, 1mM
DTT, 10% glycerol, 7mM CHAPS and loaded on a
Hitrap Heparine Sepharose CL-4B column (1ml,
Pharmacia-LKB), washed with 5 volumes HS buﬀer
(50mM HEPES pH 7.6, 1M NaCl, 0.1mM EDTA,
1mM DTT, 10% glycerol, 7mM CHAPS) and equilibra-
ted with a linear NaCl gradient (0–1M NaCl). Fractions
containing IN activity (eluted at 300mM NaCl) were
pooled and either concentrated or not by ultraﬁltration
(Centricon Millipore), followed by addition of 7mM
CHAPS. ZnSO4,5 0 mM, was added if necessary in
the stock fraction. Puriﬁed IN was kept at  808Ci n
300mM NaCl. Proteins were analyzed by electrophoresis
in a 12% SDS–PAGE and western blotting using a poly-
clonal anti-IN antibody (Invitrogen, Carlsbad, CA,
USA). Dilutions of the IN protein were carried during
various times reported in the results section in dilution
buﬀer without cation (HEPES 20mM, pH 7.6) or with
either Mg
++ (7.5mM MgCl2, HEPES 20mM, pH 7.6) or
Mn
++ (7.5mM MnCl2, HEPES 20mM, pH 7.6, stan-
dard conditions).
Detergent free enzyme was puriﬁed following the new
puriﬁcation procedure leading to INHybrid enzyme. For
that purpose CHAPS 7mM was used during extraction
but omitted during the ﬁnal puriﬁcation steps and
ZnSO4 50mM was added in all the chromatography buf-
fers described above.
Determination ofoligomerization state
Gel filtration chromatography. Puriﬁed IN was diluted in
1ml loading solution (50mM HEPES pH 7.5, 7mM
CHAPS, 1mM DTT, 150mM NaCl, 0.1mM EDTA) to
a ﬁnal enzyme concentration of 150nM and chromato-
graphed through a Smart Superose 12 (Pharmacia-LKB)
on the Ettan LC system. The void volume was determined
with blue dextran (>2000kDa) and the column was cali-
brated with aldolase (158kDa), bovine serum albumin
(67kDa), ovalbumin (43kDa) and chymotrypsinogen A
(25kDa) (Pﬁzer, Kirkland, Que ´ bec). Proteins were eluted
with a ﬂow rate of 0.04ml/min and recorded by continu-
ously monitoring the absorbance at 280nm. Prior to chro-
matography, samples were centrifuged for 10min at
10000r.p.m. to remove large protein aggregates.
Disuccinimidyl suberate crosslink. One picomole of puri-
ﬁed IN was incubated for 30min at 228C (standard con-
ditions) with 0.8mg of Disuccinimidyl suberate (DSS) in a
HEPES 50mM pH 7.5 buﬀer and at a ﬁnal NaCl concen-
tration of 30mM in a total volume of 20ml. The cross-
linked products were separated on 12% SDS–PAGE gel
and detected by western blotting using a polyclonal anti-
IN antibody (Invitrogen).
SAXS. SAXS experiments were performed as described
by Baranova et al. (17). SAXS patterns were obtained
with a Siemens diﬀractometer (Germany) by step-by-step
scanning using a goniometer and an X-ray scintilla-
tion detector. Small-angle roentgenograms were mea-
sured in the angular range h=0.013–0.22A ˚  1, where
h=4p sin / ,2  , is the scattering angle, and   is the
7044 Nucleic Acids Research, 2008, Vol. 36, No. 22X-ray wavelength. The ﬁrst step in mathematical proces-
sing of the SAXS data and computational checks of func-
tions for size distribution of spherical particles were
performed using the computer program and algorithms
describedearlier(19)aswellasoptimizationprograms(20).
In vitro activities
Processing and strand transfer. Standard assays were per-
formed as described previously (21) in 20mM HEPES
pH 7.5, 10mM DTT, 7.5mM MnCl2, 0.05% NP40 in a
total volume of 20ml. The ﬁnal NaCl concentration was
adjusted at 30mM in all reactions. The reaction mixture
was incubated at 378C for 1h in the presence of IN
(50nM) and radiolabeled oligonucleotides (50nM) and
the incubation was stopped by adding 10ml of loading
buﬀer (95% formamide, 20mM EDTA, 0.05% bromo-
phenol blue) and heating at 908C for 5min (standard con-
ditions). The reaction products were analyzed by
electrophoresis on 15% polyacrylamide gels with 7M
urea in Tris–borate–EDTA pH 7.6 and autoradiographed.
The sequence of the ODNs used to perform the processing
and strand transfer assays were the following:
ODN 70: 50GTGTGGAAAATCTCTAGCAGT30,
ODN 71: 50GTGTGGAAAATCTCTAGCA30,
ODN 72: 50ACTGCTAGAGATTTTCCACAC30.
To perform the 30 processing assay, the 50 radiolabeled
ODN 70 hybridized to ODN 72 was used as a substrate
while the 50 radiolabeled ODN 71 hybridized to ODN 72
was used as a substrate in the strand transfer reaction.
The unlabeled 21bp hybrid 71–72 was used as speciﬁc
ODN for the reassociation experiments. As a control of
speciﬁcity a 21bp random ODN was also used and
obtained by hybridization of the following ODNs:
Random21_50:5 0CGTAAGGTCATTTCAACTGAT30.
Random21_30:3 0ATCAGTTGAAATGACCTTACG30.
Concerted integration DNA substrates. Standard con-
certed integration reactions were performed as described
previously (22), except that no cellular proteins were
added. Brieﬂy, puriﬁed HIV-1 IN (50nM) was pre-incu-
bated with both the 50-end-labeled donor DNA (10ng)
containing the 30-processed U3 and U5 LTR sequences
and the target DNA plasmid pBSK
+ (100ng) at 08 C for
20min in a total volume of 5ml. Then the reaction mixture
(20mM HEPES pH 7.5, 10mM DTT, 7.5mM MgCl2,
10% DMSO, 8% PEG, 30mM NaCl) was added and the
reaction proceeded for 90min at 378C. Incubation was
stopped by adding a phenol/isoamyl alcohol/chloroform
mix (24/1/25 v/v/v). The aqueous phase was loaded on a
vertical 1% agarose gel in the presence of 1% bromophe-
nol blue and 1mM EDTA. After separation of the pro-
ducts, the gel was treated with 5% TCA for 20min, dried
and autoradiographed. All IN activities were quantiﬁed by
scanning of the bands after gel electrophoresis and auto-
radiography using the Image J software. Both target and
donor plasmids were kind gifts from Dr Karen Moreau
(Universite ´ Claude Bernard-Lyon I, France). The target
corresponds to the plasmid pBSK
+ (Stratagene, La Jolla,
California) carrying the zeocin resistance encoding gene.
The 294bp preprocessed donor substrate was obtained as
described previously (12) and contains after cleavage by
NdeI the supF tRNA gene ﬂanked by two pre-cleaved
extremities mimicking the 30-processed U3 and U5 LTR
sequences. The unprocessed donor was generated by clon-
ing a donor containing ScaI ends into a PGem-T vector
(Promega, Charbonnieres, France) as previously described
(11). The PGem-T-SupFScaI resulting vector was cleaved
by ScaI and the substrate fragment was puriﬁed.
Cloning of integration products for FSI
quantification. The same protocol described previously
(12) was used. Brieﬂy, after concerted integration the pro-
ducts were puriﬁed on a DNA puriﬁcation system column
(Promega) as described by the supplier and then intro-
duced into a MC1060/P3 Escherichia coli strain which
contained ampicillin, tetracycline and kanamycin resis-
tance genes. Both ampicillin and tetracycline resistance
genes carry an amb mutation. These proteins are thus
expressed only in the presence of the supF gene products.
Integration clones carrying both zeocin-resistance and
supF genes were therefore selected in the presence of
40mg/ml ampicillin, 10mg/ml tetracycline, 15mg/ml kana-
mycin and 25mg/ml zeocin. Plasmids were isolated from
quadruple resistant colonies and checked by PCR sequen-
cing (ABI Prism big dye terminator cycle sequencing
ready reaction kit, Applied Biosystems) using the U3
primer (50-TATGGAAGGGCTAATTCACT-30) and the
U5 primer (50-TATGCTAGAGATTTTCCACA-30).
Nonsequence-specific DNA endonuclease assay. Standard
reactions were performed as described previously (23).
Substrate of the non-sequence-speciﬁc endonuclease activ-
ity of HIV-1 integrase was the bacterial pUC19 DNA
plasmid from Gibco. Puriﬁed integrase (1pmol) was incu-
bated with 200ng of pUC19 DNA in a reaction mixture of
10ml containing 20mM HEPES pH 7.5, 10mM DTT,
0.05% NP40, 30mM NaCl and MnCl2 or MgCl2
(7.5mM). The reaction mixture was incubated up to 1h
at 378C and stopped by addition of 2ml of 95% forma-
mide, 20mM EDTA, 0.05% bromophenol blue stop solu-
tion (standard conditions). Samples were analyzed on a
1% agarose minigel containing ethidium bromide
(0.5mg/ml). Electrophoresis was carried out for 30min at
100V at room temperature. DNA was detected by ﬂuor-
escence upon exposure to UV light. Activity was evaluated
by quantiﬁcation of the bands corresponding to the diﬀer-
ent topological forms of the plasmid using the Image J
software after scanning.
RESULTS
Purification of differently associated IN
In order to analyze the dynamic association of IN
with DNA, our ﬁrst aim was to obtain diﬀerent forms
of the associated enzyme in the absence of a crosslink
agent. Several parameters can aﬀect IN oligomerization
such as enzyme concentration, presence of detergent
and Zn ions (15,16,24,25). Our standard preparations
of enzyme were all obtained in the presence of CHAPS
but diﬀer in their protein concentrations and the
Nucleic Acids Research, 2008, Vol. 36, No. 22 7045addition of Zn or not (Materials and Methods section).
Diﬀerent enzymes were obtained: (i) INLC stored at
initial protein concentration <1mM; (ii) INHC stored
at initial protein concentration 5mM; and (iii) INZn
stored at initial protein concentration 12.5mm and
50mM Zn.
The oligomerization state of each sample was
checked by size exclusion (gel ﬁltration) chromatography.
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Figure 1. Oligomerization state (A and B) and functional analyses (C and D) of the associated INZn preparation. One hundred and ﬁfty picomole of
IN puriﬁed in presence of 50mm ZnSO4 (INZn,1 0 mM) were submitted to gel ﬁltration chromatography. (A) The nature of the IN peaks was
determined by comparing proﬁles obtained with proteins of known molecular weights aldolase (158kDa), bovine serum albumin (67kDa), ovalbumin
(43kDa) and chymotrypsinogen A (25kDa). One picomole of INZn was submitted to DSS crosslink (0.8mg DSS, 50mM HEPES pH 7.5, 30mM
NaCl) for 15min and 60min at 228C and then 12% SDS–PAGE gel followed by western blot using polyclonal anti-IN antibodies. (B) Monomer
(Mo), dimer (Di) and tetramer (Te) positions were determined by comparison with a molecular weight marker (MQ). Concerted integration assay
(C) was performed without IN (lane -IN) or with 1pmol of INzn (same ﬁnal protein and NaCl concentrations of respectively 50nM and 30mM)
using 100ng of acceptor DNA (3000bp) and 10ng of
32P5 0-labelled donor pre-processed DNA (296bp). The reaction products were either loaded on
1% agarose gel or cloned in MC1060/P3 E. coli strain. The position and the structure of the diﬀerent products obtained after half-site (HSI), full-site
(FSI) and donor/donor integration (d/d) are reported. The number of resistant selected colonies obtained in absence of IN (-IN) or after integration
reaction carried by INZn (mean SD of three independent experiments) and the structure of the integration loci from 20 clones in each condition are
reported in D.
7046 Nucleic Acids Research, 2008, Vol. 36, No. 22As shown in Figure 1A, we obtained in the presence
of Zn an IN solution containing monomers, dimers
and tetramers. In contrast, all the IN preparations
obtained in the absence of Zn and in the presence of
CHAPS were dissociated (Supplementary Material 1).
The oligomerization equilibrium of the associated pre-
paration was further checked by crosslink with DSS fol-
lowed by SDS–PAGE and western blot. As shown in
Figure 1B, the data obtained using chromatography
were conﬁrmed since monomers, dimers and tetramers
were detected using this approach with similar propor-
tions than those obtained after gel ﬁltration. Longer cross-
link incubation times did not change the oligomerization
proﬁle, indicating that DSS was able to crosslink only
preformed oligomers without inducing further multimer-
ization. Same results were obtained when using the SAXS
methods (data not shown). Consequently, we assumed
that the crosslink analysis reﬂects the proportion of oligo-
mers in the IN solutions, and thus, this method was used
to evaluate all the IN preparations throughout this work.
Integrase dissociation inhibitsin vitro integration activity
The in vitro activity of the INZn preparation was checked
using the concerted integration assay. Standard reaction
was initially performed using a 294bp DNA substrate
containing the 21nt pre-processed HIV-1 viral ends at
each extremity, as described previously (12). Figure 1C
shows that the INZn enzyme was highly active since
all the expected integration products were detected.
In order to precisely monitor the full site integration
events the circular forms of integration were cloned and
quantiﬁed. As reported in Figure 1D analysis of the inte-
gration loci structure indicated that the 5bp duplications
was found conﬁrming that the enzyme catalyzed concerted
integration with a good eﬃciency and ﬁdelity. In contrast,
the dissociated enzymes mentioned above were found less
active and the IN monomers were found totally inactive
(Supplementary Material 1).
In order to determine the relationship between the activ-
ity and the oligomerization state of IN, we analyzed the
activity of the INZn preparation before and after dissocia-
tion (strategy described in Supplementary Material 2). The
highly concentrated enzyme was diluted at a protein con-
centration ranging from 12.5mm to 0.125mM and the oli-
gomerization state was checked by DSS crosslink and
quantiﬁed by densitography of the western blot analysis.
DSS crosslink analysis shown in Figure 2 indicated that
the dilution led to the dissociation of IN. Samples at con-
centrations below 1.5mM appeared mainly as monomers
under these conditions while dimers appeared when
the concentrations were increased. Tetramers were
observed only at the highest concentration of 12.5mM
of the initial stock solution, in agreement with the results
obtained by exclusion size chromatography and crosslink-
ing (Figure 1).
Diluted samples were tested in vitro for concerted inte-
gration under standard conditions (7.5mM MnCl2,
HEPES 20mM, pH 7.6), using pre-processed substrate
and FSI was quantiﬁed by selection of integrants clones.
The ﬁnal concentration of IN and NaCl were adjusted
respectively to 50nM and 30mM for each experiment.
As shown in Figure 3A and quantiﬁcation in Figure 3B,
no integration activity was detected with the dissociated
enzyme appearing as monomers in the previous DSS anal-
ysis (lanes 6–7). The integration activity was found highly
dependent on the amount of oligomers in the initial IN
solutions, especially dimers. Increasing the proportion of
oligomers also improved the level of FSI activity as shown
by the results of integrants cloning (ﬁgure 3C), without
aﬀecting the quality of the integration since no signiﬁcant
changes were observed regarding the proportion of 5bp
duplication as seen in Figure 3D. The same eﬀect was
observed when IN was diluted in presence of Mg
++ or
in the absence of cations (data not shown).
The viral end structure was previously found to aﬀect
the in vitro concerted integration activity (11). To deter-
mine whether the inhibition of the activity concomitant
with IN dissociation was dependent on the viral end struc-
ture from the donor DNA, we used a DNA carrying the
intact unprocessed 21nt LTR ends. The substrate was
generated using a DNA fragment containing the ScaI
restriction site as reported previously (11). Using this sub-
strate a higher proportion of FSI was detected (Figure 4).
Analysis of the integration loci indicated that the use of
intact viral ends improved both, the eﬃciency and the
quality of the integration (Figure 4C and D, to be
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Figure 2. Eﬀect of enzyme initial concentrations on IN oligomerization
in solution. One picomole of each diluted fraction was submitted to
DSS crosslinking. Then monomer, dimer and tetramer bands were
quantiﬁed using the Image J software. The percentage of each oligomer
was plotted versus the initial IN concentration.
Nucleic Acids Research, 2008, Vol. 36, No. 22 7047compared with Figure 3C and D), thus conﬁrming a pre-
vious report (11). However, as observed with the pre-
processed substrate, IN dissociation led to the inhibition
of integration without aﬀecting the quality of the integra-
tion (no change was observed in the integration loci struc-
ture as seen in Figure 4D). The proﬁle obtained with the
unprocessed substrate remained similar to that observed
with the pre-processed DNA except the inhibition rate that
was found diﬀerent since FSI and HSI appeared less tol-
erant to the dissociation step (compare Figure 4B to 3B).
This indicates that the initial oligomerization state of IN
in solution aﬀects the eﬃciency of the integration reaction
independently of the viral end structure. Since the quality
of the integration was found to be highly dependent on the
formation of the synaptic IN tetramer complex on viral
ends (12), our data suggest that only the initial attachment
step was aﬀected by the dissociation and not the ﬁnal
active complex structure. Furthermore, since integration
activity appeared only in the presence of oligomers
in solution we concluded that either preformed active oli-
gomers can exist in solution, or that preformed oligomers
in solution are required to be activated on DNA.
The striking result obtained with the IN samples
dissociated into monomers suggested that, under our con-
ditions, monomers of IN are inactive probably because
they were unable to associate on DNA to form the
active oligomers. Therefore, it was tempting to speculate
that preformed oligomers (dimers or tetramers) could bind
directly to DNA to form the active IN DNA complexes.
The inactivity of the IN monomers on a long DNA
substrate used for the concerted integration assay could
be due to their inability to bind DNA, to catalyze the
integration reaction and/or to actively oligomerize on
viral ends. To answer this question we further analyzed
the functional association of dissociated preparations of
IN focusing on short ODN mimicking the viral end.
Integrase monomers can actively associate onshort
ODN mimicking the viral endsto catalyze
3’ processing and strandtransfer activities
Dissociated samples after dilution were tested for their
folding into active complexes on short DNA carrying
only the ﬁnal 21bp of viral LTR or nonspeciﬁc sequences.
Surprisingly, dissociated INzn (0.125mM) was able to cat-
alyze the processing (Figure 5A) and the strand transfer
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Figure 3. Eﬀect of initial IN concentrations on in vitro integration of the pre-processed donor DNA. Concerted integration assay was performed with
1pmol of IN from the diﬀerent diluted preparations of INZn as shown (D): 12.5mM (lane 1), 6.25mM (lane 2), 3.125mM (lane 3), 1.56mM (lane 4),
0.78mM (lane 5), 0.3mM (lane 6) and 0.125mM (lane 7). The ﬁnal NaCl concentration was adjusted to 30mM in all assays. The reaction products
were either loaded on 1% agarose gel (A) or cloned in MC1060/P3 E. coli strain (C). The position and the structure of the diﬀerent products
obtained after half-site (HSI), full-site (FSI) and donor/donor integration (d/d) are shown (A). (B) corresponds to the densitometry estimation of the
FSI and FSI+HIS bands of experiments shown in A. The diﬀerent integration products were quantiﬁed using the Image J software. Values are the
mean SD (error bars) of three independent experiments. The number of resistant selected colonies (C) obtained after integration reaction carried by
the diﬀerent diluted IN and the structure of the integration loci (D) from 20 clones in each condition are reported.
7048 Nucleic Acids Research, 2008, Vol. 36, No. 22reactions (Figure 5B). However, this activity was revealed
only when incubations were performed at times longer
than the standard conditions (2h instead of 1). This sug-
gests that IN monomers can fold into active complexes
when bound to short speciﬁc DNA in contrast to the
situation with the longer substrate used for concerted inte-
gration assay.
However, standard processing reactions were per-
formed using Mn
++ while concerted integration assays
were done in the presence of Mg
++ or not. Since diﬀerent
metal ions are known to aﬀect IN conformational changes
(26–28), we performed new processing experiments using
Mg
++ cations. As reported in Figure 5C, the use of
Mg
++ decreased the activity for both associated and dis-
sociated IN with a more dramatic eﬀect on enzyme mono-
mers. Indeed, no activity was observed after 2h using
monomers while a signiﬁcant activity of the associated
IN activity was observed. Since the associated IN activity
was also aﬀected by the nature of the cations, it remains
diﬃcult to conclude about the eﬀect of Mg
++ on the
active complexes. However, it has previously been shown
that the half-life of IN DNA complexes is dependent upon
the cations (29,30) and lower in the presence of Mg
++.
One explanation why the 30 processing catalyzed by
monomers was more severely impaired in presence of
Mg
++ could be the lower stability of the complexes
formed from the sequential recruitment of a second mono-
mer by a ﬁrst one already bound to DNA. This also sug-
gests the emergence of a more stable complex issued from
the binding of IN oligomers explaining why the associated
IN remains active even in presence of Mg
++.
The hypothesis of diﬀerences in the kinetic and stability
of the complexes depending of the cations was (i) con-
ﬁrmed by the detection of some processing activity
for IN monomers in experiments performed after lon-
ger reactions time (more than 4h) in presence of Mg
++
(Supplementary Material 3) and (ii) strongly supported by
the following reassociation experiments.
Reactivation ofintegrase monomers by short specific ODNs
IN monomers appeared inactive on long DNA while they
present 30 processing and strand transfer activity on short
speciﬁc viral sequences. This indicates that they can bind
DNA and actively oligomerize on the viral end. Thus, the
inactivity of monomers on long DNA substrate could be
due to their ineﬃciency to be positioned on the viral ends
in contrast to the associated forms which could bind more
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Figure 4. Eﬀect of initial IN concentrations on in vitro integration of the unprocessed donor DNA. Concerted integration assay was performed with
1pmol of IN from the diﬀerent diluted preparations of INZn as shown in Figure 3: 12.5mm (lane 1), 6.25mm (lane 2), 3.125mm (lane 3), 1.56mM (lane
4), 0.78mm (lane 5), 0.3mm (lane 6) and 0.125mM (lane 7). The ﬁnal NaCl concentration was adjusted to 30mM in all reaction solutions. The
reaction products were either loaded on 1% agarose gel (A) or cloned in MC1060/P3 E. coli strain (C). The position and the structure of the diﬀerent
products obtained after half-site (HSI), full-site (FSI) and donor/donor integration (d/d) are shown in (A). (B) corresponds to densitometry of the
FSI and FSI+HIS bands of experiments shown in A. The diﬀerent integration products were quantiﬁed using the Image J software. Values are the
mean SD (error bars) of three independent experiments. The number of resistant selected colonies (C) obtained after integration reaction carried by
the diﬀerent diluted IN and the structure of the integration loci (D) from 20 clones in each condition are reported.
Nucleic Acids Research, 2008, Vol. 36, No. 22 7049speciﬁcally the end sequence to form the active complexes.
If this hypothesis is correct, the reassociation of mono-
mers into dimers should lead to the reactivation of the
dissociated preparation of IN. It has been described pre-
viously that the preincubation of IN with short ODNs
leads to its oligomerization and to the activation of 30
processing reaction (17,18), suggesting that active oligo-
mers could be released from the IN DNA complex. To
verify this point, we performed a reassociation experiment
of IN monomer preparations.
One picomole of dissociated INZn was incubated over-
night with 1pmole of the 21nt ODN presenting the LTR
ends or random nonviral ODN under our standard con-
ditions (7.5mM MnCl2, HEPES 20mM, pH 7.6). The self
association of the protein was analyzed using DSS cross-
link before performing concerted integration assays.
Results in Figure 6 indicate that preincubation of the dis-
sociated enzyme with either short speciﬁc viral ODN or
random ODN led to its reassociation into oligomers
(mainly dimers). These data have been validated by
SAXS experiments (data not shown) conﬁrming that
monomers can bind either to speciﬁc or nonspeciﬁc
DNA and associate on it. In order to determine whether
the oligomers formed on both ODN were functionally
similar, we tested the reassociated fractions in concerted
integration assays. Results are reported in Figure 7A and
show that the incubation of IN monomers with the 21nt
viral ends led to recovery of integration (lane 3 compared
to lane 2). In contrast, no integration was detected after
incubation with nonviral ODN (lane 4), indicating that,
in this case, the multimer enzyme was inactive. Selection
of integrants carrying the circular form of FSI products
indicated that this reaction was also recovered, at least
partially, when the dissociated enzyme was pre-incubated
with speciﬁc ODN but not with random sequences
(Figure 7B). Sequencing of the integration loci showed
a similar proﬁle with associated and reassociated IN.
The eﬀect of the viral end structure was also analyzed
using the blunt substrate for the concerted integration
assay. As reported in Figure 7C and D, the same reactiva-
tion was observed under these conditions, conﬁrming that
the enzyme dissociation aﬀected the early steps of IN
attachment to DNA and not the formation of the ﬁnal
synaptic complex.
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Figure 5. IN activity and oligomerization on short ODN mimicking the viral ends. 1pmole of associated (12.5mM initial concentration) and
dissociated (0.125mM) INZn were analyzed for 30 processing (A) and strand transfer activities (B). Reactions were performed under standard
conditions (7.5mM MnCl2, 20mM HEPES pH 7.6) for 0 to 120min. The ﬁnal NaCl concentration was adjusted to 30mM in all reaction solutions.
IP, integration product; P, processing product. 30 processing activity detected after 120min of reaction with both enzyme preparations was analyzed
using either MgCl2 or MnCl2 (7.5mM) and the percentage of activity recovered was reported in C. Results are the mean SD (error bars) of three
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Figure 6. Eﬀect of speciﬁc and nonspeciﬁc ODN on integrase self asso-
ciation. One picomole of INzn 12.5mm or 0.125mM (lanes 1 and 2) pre-
incubated with speciﬁc or nonspeciﬁc 21bp ODN (lanes 3 and 4) were
submitted to DSS crosslink for 30min at 228C and loaded on 12%
SDS–PAGE before western-blotting with polyclonal anti-IN antibody.
In all reactions the ﬁnal NaCl concentration was adjusted to 30mM.
Monomer (Mo), dimer (Di) and tetramer (Te) positions were deter-
mined by comparison with a molecular weight marker (MQ).
7050 Nucleic Acids Research, 2008, Vol. 36, No. 22Interestingly, the reassociated monomers obtained
after preincubation with the speciﬁc ODN were also
found more active for 30 processing especially when
reaction was performed in presence of Mg
++ (Supple-
mentary material 3). This conﬁrmed that the diﬀerences
of activity observed between Mg
++ and Mn
++ condi-
tions were due to diﬀerences in kinetics. In addition,
the same re-association and reactivation eﬀects were
observed when the experiments were performed with
IN diluted in presence of Mg
++ (7.5mM MgCl2,
HEPES 20mM, pH 7.6) (data not shown) demonstrat-
ing that the reassociation of monomers into oligomers
and their reactivation were not only Mn
++ dependent.
Furthermore, the reassociation experiments performed
with other IN preparation obtained with diﬀerent pur-
iﬁcation procedures described in Materials and methods
section led to the same results demonstrating that the
reassociation of monomers into active oligomers was
not dependent of the puriﬁcation method (Supplemen-
tary material 4).
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Figure 7. Eﬀect of reassociation of INZn on in vitro integration activity. Assays were performed with 100ng receptor DNA and 10ng pre-processed
(A) or unprocessed donor (C) with 1pmol of INzn 12.5mm or 0.125mM diluted in standard dilution buﬀer (7.5mM MnCl2, HEPES 20mM, pH 7.6)
without preincubation (respectively lanes 1 and 2) or after preincubation with 1pmol of speciﬁc 21bp viral ODN (lanes 3) or random 21bp ODN
(lane 4) under standard conditions (7.5mM MnCl2, HEPES 20mM, pH 7.6). The reaction products were then loaded on 1% agarose gel. The
position and the structure of the diﬀerent products obtained after half-site (HSI), full-site (FSI) and donor/donor integration (d/d) are reported in the
ﬁgure. Eﬀect of reassociation on full site integration. Reaction products obtained with the pre-processed (B) or the unprocessed (D) donor were
cloned in MC1060/P3 E. coli strain as described in Materials and methods section. The number of resistant selected colonies obtained after
integration reaction under the diﬀerent conditions is reported in the ﬁgure. Results are the mean SD (error bars) of three independent experiments.
Nucleic Acids Research, 2008, Vol. 36, No. 22 7051In order to obtain more information on the mechanism
of reactivation, we examined the kinetic of reactivation of
the dissociated INZn enzyme in presence of Mg
++ or
Mn
++. As shown in Figure 8, the kinetic of reactivation
was found diﬀerent when comparing both conditions.
Indeed, the activation detected in presence of Mg
++
was observed after 2h and was maximal at 6h. In con-
trast, when Mn
++ was used the activation was not
detected before 10h. These results are consistent with
the half-life of the IN DNA complexes determined
before in the presence of both cations (31). Taken together
these results indicate that monomer reactivation was
mainly due to IN reassociation on short ODNs followed
by the release of active oligomeric complexes. But the
previous demonstration of the displacement of viral
DNA termini from stable IN nucleoprotein complexes
induced by the secondary DNA binding interaction (31)
meant that we could not rule out a possible tertiary com-
plex between IN, the short ODN and the concerted inte-
gration substrate as a possible mechanism of activation.
Our major observation is that both ODNs led to the
formation of oligomers, mostly dimers, from monomers,
but only speciﬁc viral DNA led to active integration com-
plexes. We conclude that active dimers can be formed
from monomers only after oligomerization of the
enzyme on the speciﬁc 21nt viral ends. Furthermore the
close association proﬁle obtained in both preincubation
conditions (speciﬁc or nonspeciﬁc ODN) and the diﬀer-
ence of in vitro activity summarized for INZn in Table 1
strongly indicate that the dimeric complexes fold on each
type of DNA are functionally diﬀerent.
Taken together these data strongly suggest that the inef-
ﬁciency of monomers to catalyze integration on long
DNA substrate was mainly due to their inability to
become adequately positioned on the viral ends, where
their association should lead to active dimers. Since,
under in vitro integration assay conditions in presence of
long substrates, IN mainly interacts with nonspeciﬁc
DNA, we further studied the function of the IN DNA
complexes formed on these nonviral sequences.
IN monomers association on nonspecific DNA leads
to double-strand endonuclease activity
Previous reports indicated that IN displays an endonu-
cleolytic non-sequence-speciﬁc activity on heterologous
DNA (23, 32). However, neither the role of this activity
nor the nature of IN forms catalyzing the cleavage has
been determined. We investigated the activity of the oli-
gomers induced by the binding to nonspeciﬁc ODNs. The
activity of the associated and dissociated preparations of
IN (INZn, 12.5mm and 0.125mM) were compared using the
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Figure 8. Eﬀet of cations on the kinetic of reactivation of dissociated
INZn. One picomole of dissociated INzn 0.125mM was preincubated
with speciﬁc 21bp ODN for 0–24h in presence of Mg
++ or Mn
++
(7.5mM) and then tested for concerted integration. Enzyme activity
was compared to that of the dissociated INZn incubated under the
same condition but without ODN. The percentage of activation was
reported.
Table 1. Summary of the association and activity analyses of the diﬀerent enzyme preparations
NSpe Spe No No Preincubation
Mo, 
Di, Te
Mo, Di Mo Mo, Di, 
Te
Oligomerization
INZn Enzymes
0.125 12.5 Concentration (µM)
Mo Mo, Di, 
Te
Oligomerization
Activity on 
long 
substrates
(294bp)
Activity on 
short ODNs
(21bp)
− + − ++ FSI
− ++ − +++ HSI
+ +++ Strand transfer
+ +++ 3′ Processing
− +++ −
− ++ −
Mo, Di Mo, Di Mo
NSpe Spe No
+
+
Mo
1
INLC
− ++ − ++
− +++ − +++
Mo, 
Di, Te
Mo, Di Mo Mo, Di, 
Te
NSpe Spe No No
+ +++
+ +++
Mo Mo, Di, 
Te
1 50
INHybrid
The INZn,I N LC (puriﬁed in presence of 7mM CHAPS in addition or not of 50mM ZnSO4) were compared for self association, 30 processing, strand
transfer, HSI and FSI products after pre-incubation or not (No) with speciﬁc (Spe) or nonspeciﬁc (NSpe) 21bp ODN. The presence of oligomers was
evaluated by DSS crosslink and western blotting, monomers (Mo), dimers (Di) and tetramers (Te) are reported. In vitro activities were quantiﬁed
using Image J software or counting of FSI integrant clones. More than 20% of 30 processing and strand transfer (+++), 5–20% (+), 15–25% of
HSI (+++), 5–15% (++), no activity ( ), Above 100 FSI integrant clones (+++), 50–100 (++), 10–50 (+). All the activities reported here
were obtained under standard conditions (7.5 MnCl2 for 30 processing and strand transfer; 7.5 MgCl2 for concerted integration). Pre-incubations with
ODN were performed in presence of MgCl2 during 16h.
7052 Nucleic Acids Research, 2008, Vol. 36, No. 22nonspeciﬁc DNA cleavage assay previously described (23).
The enzyme displaying a mixture of monomers, dimers
and tetramers presented a classical proﬁle of single-
strand non-sequence-speciﬁc DNA (Figure 9A, quantiﬁed
in Figure 9B). Interestingly, the monomers showed a dif-
ferent proﬁle characterized by the formation of linear
molecules indicating a double-strand DNA endonuclease
activity (Figure 9A quantiﬁed in Figure 9C). Both single-
strand and double-strand DNA cleavages were inhibited
by the IN-speciﬁc ODN inhibitor 93 del (33,34), indicating
that the breaks were due to intrinsic IN activity.
Since Mg
++ and Mn
++ have been shown to inﬂuence
the speciﬁcity of the enzyme (27,28,30), we further studied
the eﬀect of both cations on the nonspeciﬁc cleavage cat-
alyzed by IN. Figure 9D and E show that double strand
DNA cuts catalyzed by the dissociated enzyme were less
tolerant to the cations used in the assay. Indeed Mg
++
decreased the double strand cleavage activity without
inducing signiﬁcant changes in the single strand cuts cat-
alyzed by the associated IN. These results support the data
obtained in the speciﬁc processing cleavage (Figure 5C)
indicating that the complexes issued from the association
of monomers on DNA may require Mn
++ to be eﬃcient
in contrast to the IN DNA complexes obtained from the
association of preformed IN oligomers on the substrate.
This could be linked to the better stability of these com-
plexes in presence of Mn
++ as previously observed (29).
Since monomers were able to oligomerize on nonviral
DNA without displaying speciﬁc IN integration activity,
we may propose that the dimers formed from monomers
on unspeciﬁc DNA (i) acquired a new non-sequence-
speciﬁc endonucleolytic activity and (ii) were functionally
and probably structurally diﬀerent from the dimers folded
on viral ends.
DISCUSSION
The initial interaction of IN with its substrate is a crucial
step for the speciﬁc recognition of the viral ends and deter-
mines the following phases of the integration reaction. It
has been proposed that during integration, changes in the
oligomerization state of IN may lead to the formation of
several forms displaying diﬀerent functions (12,17). Even
if all the data point to the requirement of a stable synaptic
complex involving an IN tetramer and both viral LTR
(12,13), the precise folding pathway of this complex on
the viral ends remains to be established. The use of
enzyme preparations with diﬀerent oligomerization pro-
ﬁles, described in this work, sheds new light on the early
events of integration in vitro and the role of IN oligomers
in the initial steps. Functional and structural analyses
of the diﬀerent IN preparations are summarized in
Table 1.
Formation of active SSCIN DNA complexes depends
on dimers binding to viralsequences or early
dimerization on viral ends
All the preparations of IN monomers used in our work
and obtained following diﬀerent procedures were found
inactive for integration using a 294bp DNA containing
the 21nt viral ends processed or unprocessed at both
ends. In contrast, IN oligomers were able to display inte-
gration activity. SAXS and crosslink experiments showed
that IN monomers were able to oligomerize both on short
speciﬁc and nonspeciﬁc DNA (Figure 6). However, oligo-
mers generated either on speciﬁc or nonspeciﬁc substrates
diﬀered in their activity (Figure 7).
Analysis of monomer activities on a short ODN
mimicking the viral ends showed that they retained low
but signiﬁcant processing and strand transfer activities
(Figure 5 and Supplementary Material 3). In addition,
integration activity was recovered after reassociation on
speciﬁc viral ODN in contrast to nonspeciﬁc ODN
(Figure 7). Thus, the lack of monomers activity on
longer DNA mimicking the viral substrate was not due
to an oligomerization or a catalytic deﬁciency but to
inadequate positioning of IN on the speciﬁc viral ends,
leading to incorrect binding in internal positions on the
DNA molecule competing with the shorter speciﬁc viral
ends. Consequently (i) the formation of active IN com-
plexes on DNA directly depends on the correct position-
ing of IN on viral ends and (ii) dimers folded on speciﬁc or
nonspeciﬁc DNA are not functionally similar. This is
strongly supported by our previous structural analysis
using SAXS method of the IN DNA complexes formed
on both type of ODN leading to the identiﬁcation of
dimers diﬀering in their radii of gyration [type 1 on speciﬁc
DNA and type 2 on nonspeciﬁc DNA, Ref. (17)].
Correct positioning on viral endsis dependent onIN
oligomerization or viralsequences accessibility to
monomer binding
The results obtained with associated preparations of IN
and the reactivation of monomers by preincubation with
speciﬁc ODN (see summary in Table 1) strongly suggest
that preformed active oligomers, especially dimers, can
bind the viral ends as functional complexes while mono-
mers can not. This is ﬁrmly supported by the demonstra-
tion that puriﬁed cross-linked oligomers retain in vitro
activity in contrast to monomers (12).
Previous binding studies did not show any signiﬁcant
diﬀerence of IN aﬃnity for either the speciﬁc 21nt viral
derivative or for nonspeciﬁc random ODNs (18). In addi-
tion, we and others observed that retroviral IN protected a
larger region above 100bp beyond the 21nt speciﬁc LTR
sequence on the integration substrate in vitro (35–37).
Thus, during in vitro assays there is a higher probability
for IN to bind the longer nonspeciﬁc internal region of the
substrate and thus to form inactive oligomers, as reported
above.
Consequently we propose two ways to form active com-
plexes: (i) by direct binding of preformed active (or ‘acti-
vable’) dimers on viral ends; (ii) by binding of IN
monomers and further dimerization on viral ends. In the
ﬁrst case, the formation of the active complexes is highly
dependent of the oligomerization state of the enzyme
interacting with DNA, as supported by the diﬀerence of
activity observed for dissociated and associated IN. Our
data obtained with IN monomers clearly indicate that in
this case the binding to viral ends is poorly eﬃcient,
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Figure 9. Non-sequence-speciﬁc endonuclease activity of IN preparations (A quantiﬁed in B and C). One pmole of associated (12.5mM initial
concentration) and dissociated (0.125mM) INZn were incubated 0–60min with 200ng of pUC19 plasmid in standard conditions (7.5MnCl2,
20mM HEPES pH 7.6). The ﬁnal NaCl concentration was adjusted to 30mM in all reaction solutions. Same reactions were performed for 1h
in presence of 10nM of the 93del inhibitor aptamer. The Close Circular (CC), Open Circular (OC) and Linear (L) forms of the plasmid are shown
and quantiﬁed. The percentage of each form was plotted versus time for each reaction conditions performed with the 12.5mM (B) and 0.125mM (C)
INZn. Values are the mean SD (error bars) of three independent experiments. Eﬀect of cations on the single strand DNA cuts catalyzed
by associated INZn (D) and double strand DNA cuts catalyzed by dissociated INZn (E). One picomol of dissociated INZn (0.125mM) was incubated
0–120min with 200ng of pUC19 plasmid in standard conditions and in the presence of either 7.5mM MnCl2 (standard conditions) or 7.5mM
MgCl2. The ﬁnal NaCl concentration was adjusted to 30mM in all reaction solutions. The Close Circular (CC), Open Circular (OC) and Linear (L)
forms of the plasmid were quantiﬁed and the percentages of single and double strand cuts were reported. Values are the mean SD (error bars) of
two independent experiments.
7054 Nucleic Acids Research, 2008, Vol. 36, No. 22probably due to the low aﬃnity of IN for viral sequences
in comparison to unspeciﬁc DNA. This is strongly sup-
ported by recent analysis from Deprez and co-workers
revealing a nonspeciﬁc DNA binding mode of the
enzyme and an optimal activity leading to DNA binding
and cooperativity (38), conﬁrming the requirement for
dimers assembling on viral ends.
Additional nonspeciﬁc DNA binding factors may opti-
mize the IN positioning on its substrate. Vpr, a compo-
nent of the PIC, has been previously shown to be a
nonspeciﬁc DNA binding protein (39,40). In addition,
the Ct terminal (52–96) domain of the protein was
shown to stimulate in vitro homologous strand transfer
of mini-viral DNA (41). The HIV-1 nucleocapsid protein,
NCp7, has been shown to activate in vitro integration by
an undetermined mechanism (42). Our data raise the ques-
tion of whether such DNA binding proteins if present in
the PIC should be required to help the correct positioning
of IN by binding to nonspeciﬁc DNA sequences. Since no
data indicate an important role for such proteins in inte-
gration during infection, the eventual physiological rele-
vance and the mechanism of IN positioning by these
factors remain to be established.
INmonomers oligomerization on nonspecificDNA leads
to complexes having double-strand nonsequence-specific
DNA cleavage activity
Single-strand endonuclease activity has been previously
described for HIV-1 IN (23,32). This activity was assumed
to reﬂect an ineﬃcient 30 processing reaction on an aber-
rant DNA substrate. As shown in Figure 9, dissociated IN
displayed a new double-strand DNA cleavage activity on
nonspeciﬁc DNA in contrast to the associated forms of the
enzyme. Even if the physiological relevance of this activity
remains to be elucidated some aspects of the struc-
ture of the IN DNA complexes can be highlighted. Our
main conclusion is that dimers formed on viral ends
and those formed on unspeciﬁc DNA are functionally
and probably structurally diﬀerent as supported by the
demonstration by SAXS of types 1 and 2 dimers folding
on respectively speciﬁc and nonspeciﬁc DNA and diﬀering
in their radii of gyration (17).
The 30 processing and the single-strand DNA nuclease
activity observed with associated IN are catalytically
similar but diﬀer in speciﬁcity suggesting that the same
dimers (type 1) are involved in both reactions and could
fold on both viral ends to form the active complexes
performing single-strand 30 processing of the LTR. In
addition, a recent study reports that a two-LTR junction
could be cleaved on both strands by a tetramer of IN
probably formed by the juxtaposition of two type 2
dimers cutting each strand at the speciﬁc CA sequence
(43). Some structural data support this hypothesis: the
C-terminal domain of one monomer acts with the central
catalytic domain from another monomer at each viral
DNA end. In this dimer one monomer could carry the
catalytic property as well as the substrate capture (44)
while the other monomer could be involved in the correct
folding of the complex. This would result in an asym-
metric dimer, as suggested by crosslink experiments
indicating that no trimers of IN could be detected,
which in turn suggested that intra-dimer and inter-dimer
contacts in the tetramer are not equivalent (12,13). Thus,
in asymmetric dimers (type 1), one catalytic site could be
positioned for the DNA cleavage on one strand and espec-
ially for the 30-end processing of the LTR, as described
for other proteins from the same family where this asym-
metry deﬁnes the single strand cut [Mu, Cre transposases
(45,46)]. More recently modelling analyses on the complex
between the IN active site and viral DNA also suggest that
only the active sites from two central monomers in con-
trast to distal ones could be involved in the 30 processing
leading to asymmetrical dimers in the active tetramer (47).
On the basis of this model, we propose that the IN
type 1 dimers could diﬀer from type 2 IN dimers formed
on the nonspeciﬁc sequence by the symmetrical position-
ing of both catalytic sites on the complex. Consequently,
the nature of the tetramer resulting from the contact
between two dimers depends on the nature of each
dimer. A recent single-image reconstitution of a tetramer
of IN bound to DNA showed that the complex probably
involves asymmetrical interactions (48). This conﬁrms that
the ﬁnal active SSC complex is probably folded from
diﬀerent types of dimers.
Amodel forthe invitro positioning ofHIV-1 IN on viralends
Our in vitro data led us to propose a model described in
Figure 10 for the initial attachment of IN on viral DNA.
IN can bind DNA under all the diﬀerent oligomeric forms
including monomers. Interaction between IN monomers
and DNA might induce oligomerization of the enzyme,
leading to dimers and tetramers whose structures and
functions depend of the bound DNA sequence. Interac-
tion between monomers and nonspeciﬁc DNA induce the
formation of dimers inactive for processing, strand trans-
fer and integration activities (type 2) but displaying a
non-sequence-speciﬁc double strand endonuclease activity
(way A). The interaction of monomers with the speciﬁc
21nt viral DNA end sequence would allow the formation
of type 1 dimers able to catalyze processing and strand
transfer reactions in the so-called Strand Transfer Com-
plex (way B), (13).
In the presence of longer DNA containing both short
speciﬁc DNA regions and larger unspeciﬁc domains and in
the absence of targeting to the speciﬁc ends (standard
in vitro conditions), IN would bind with higher frequency
to nonspeciﬁc sequences. This would lead mainly to the
formation of inactive type 2 dimers (way A). In solution
and especially in associated IN preparations, preformed
dimers (including types 1 and 2) are present. Type 1
dimers bind the viral ends better than nonspeciﬁc DNA
[the type 1 dimer association with the speciﬁc viral ends
was found to be more stable, Ref. (17)] and perform the
integration reaction either without or after structural
changes, thereby allowing the formation of the active tet-
ramer synaptic complex (SSC), (way B). In contrast to
monomers a better interaction of associated IN with
viral ends can be explained by the closed structure adopted
by IN and revealed by single-image reconstitution of a
tetramer of IN bound to DNA (48). This study suggests
Nucleic Acids Research, 2008, Vol. 36, No. 22 7055the presence of a central channel resembling a variety of
other DNA-binding proteins wrapped around their sub-
strate. In the preformed dimer the only way to interact
with DNA could be the entry of the DNA substrate end
inside the channel. That process would favour the speciﬁc
binding of the enzyme to the viral ends. In contrast the
monomer could bind the DNA at an internal position of
the substrate before recruiting another monomer to wrap
the DNA around the channel favouring interactions with
multiple nonspeciﬁc binding sites. This mechanism could
require a better stability of the IN DNA complex as sug-
gested by the better activity observed for dissociated IN
preparations in all assays performed with Mn
++, cations
known to increase the half-life of these complexes
(29, Figures 5 and 8).
Consequently, we propose that IN oligomerization con-
trols both the enzyme speciﬁcity and its activity on DNA.
Despite some diﬀerences observed in the kinetics per-
formed in presence of Mg
++ or Mn
++ similar conclu-
sions were raised indicating that our in vitro observations
could also be relevant in the case of infected cells. In the
cell the formation of active type 1 dimers and integration
must be optimal. This is especially important since we
show here that the dimerization IN on non-LTR
sequences leads to the formation of dimer complexes
having a double-strand DNA cleavage activity able to
digest the viral genome if unprotected. Viral factors of
the PIC, displaying nonspeciﬁc DNA-binding properties,
may be involved in IN to the speciﬁc viral ends by mask-
ing IN nonspeciﬁc DNA binding sites and protecting
the viral genome. Strategies aimed to stimulate genome
destruction on the basis of this proposal appear as a
new therapeutic axe to be developed.
The precise structure of each oligomer variant remains
to be resolved. A priority should be to conduct structural
studies of the IN complexed to the two viral ends. Studies
of the enzyme structure in complex with nonspeciﬁc DNA
and with one speciﬁc DNA end should provide interesting
data on types 1 and 2 dimers, respectively, and should
conﬁrm their structural diﬀerences. The detailed biochem-
ical study of the conditions leading to the formation of
speciﬁc active oligomers of HIV-1 IN, as described here,
should be useful to accomplish these structural studies.
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